insights_auto
Why is ABCL down 9.37%?
Dive Deeperchevron_right
ABCL:NASDAQ
AbCellera Biologics Inc
$11.12
arrow_downward
-9.37%(-1.15) 1D
$11.15
arrow_upward
+0.27% (+0.030)bedtimeAfter hours
Closed: Nov 2, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ABCL...
Open
$12.33
High
$12.33
Low
$11.05
Mkt. cap
3.60B
Avg. vol.
4.74M
Volume
3.04M
52-wk high
$15.02
52-wk low
$2.74
EPS
-$0.54
Beta
1.41
Shares outstanding
324.05M
No. of employees
562
Open
$12.33
High
$12.33
Low
$11.05
Mkt. cap
3.60B
Avg. vol.
4.74M
Volume
3.04M
52-wk high
$15.02
52-wk low
$2.74
EPS
-$0.54
Beta
1.41
Shares outstanding
324.05M
No. of employees
562
News stories
From web sources and news partners
Seeking Alpha
·
14 minutes ago
Nasdaq And S&P 500 Index Lose Momentum, Pull Down Market
www.foreignpolicyjournal.com
·
25 minutes ago
Billions In Cash Burn Separate IREN And Applied Digital (NASDAQ: APLD) As AI Infrastructure Race Heats Up
GreenevilleSun.com
·
17 minutes ago
More drops for AI and tech stocks overshadow gains for most of Wall Street
Bloomberg.com
·
12 minutes ago
Nasdaq Slide Clouds Asian Open, Oil Falls on Iran: Markets Wrap
Profile
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia. Wikipedia
About AbCellera Biologics Inc
CEOCarl Hansen
Employees562
Founded2012
HeadquartersVancouver, British Columbia, Canada
SectorHealth care
Websiteabcellera.com